These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 30868010)

  • 1. Incidence of Pancreatic Adenocarcinoma in the United States from 2001 to 2015: A United States Cancer Statistics Analysis of 50 States.
    Patel N; Khorolsky C; Benipal B
    Cureus; 2018 Dec; 10(12):e3796. PubMed ID: 30868010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Esophageal Cancer in the United States from 2001-2015: A United States Cancer Statistics Analysis of 50 States.
    Patel N; Benipal B
    Cureus; 2018 Dec; 10(12):e3709. PubMed ID: 30788198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Gastrointestinal Stromal Tumors in the United States from 2001-2015: A United States Cancer Statistics Analysis of 50 States.
    Patel N; Benipal B
    Cureus; 2019 Feb; 11(2):e4120. PubMed ID: 31037234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Neuroendocrine Tumors in the United States from 2001-2015: A United States Cancer Statistics Analysis of 50 States.
    Patel N; Benipal B
    Cureus; 2019 Mar; 11(3):e4322. PubMed ID: 31183301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Cholangiocarcinoma in the USA from 2001 to 2015: A US Cancer Statistics Analysis of 50 States.
    Patel N; Benipal B
    Cureus; 2019 Jan; 11(1):e3962. PubMed ID: 30956914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer incidence trends in the United States from 2000-2017: Analysis of Surveillance, Epidemiology and End Results (SEER) database.
    Ali H; Pamarthy R; Vallabhaneni M; Sarfraz S; Ali H; Rafique H
    F1000Res; 2021; 10():529. PubMed ID: 34527218
    [No Abstract]   [Full Text] [Related]  

  • 7. Mapping the Hidden Terrain of Hepatocellular Carcinoma: Exploring Regional Differences in Incidence and Mortality across Two Decades by Using the Largest US Datasets.
    Abboud Y; Shah VP; Bebawy M; Al-Khazraji A; Hajifathalian K; Gaglio PJ
    J Clin Med; 2024 Sep; 13(17):. PubMed ID: 39274469
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
    Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
    Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
    Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
    BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the Incidence of Pancreatic Adenocarcinoma in All 50 United States Examined Through an Age-Period-Cohort Analysis.
    da Costa WL; Oluyomi AO; Thrift AP
    JNCI Cancer Spectr; 2020 Aug; 4(4):pkaa033. PubMed ID: 33490862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of pancreatic cancer in the United States: changes below the surface.
    Shaib YH; Davila JA; El-Serag HB
    Aliment Pharmacol Ther; 2006 Jul; 24(1):87-94. PubMed ID: 16803606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States.
    Aschebrook-Kilfoy B; Kaplan EL; Chiu BC; Angelos P; Grogan RH
    Ann Surg Oncol; 2013 Aug; 20(8):2746-53. PubMed ID: 23504142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
    Milano AF
    J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.
    Chen AY; Jemal A; Ward EM
    Cancer; 2009 Aug; 115(16):3801-7. PubMed ID: 19598221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
    Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
    J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analysis Using 2001-2018 United States Cancer Statistics Databases.
    Jiang Y; Abboud Y; Liang J; Larson B; Osipov A; Gong J; Hendifar AE; Atkins K; Liu Q; Nissen NN; Li D; Pandol SJ; Lo SK; Gaddam S
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging incidence trends and application of curative treatments of pancreatic cancer in the USA.
    Pei X; Song F; Wang Z
    Medicine (Baltimore); 2019 Dec; 98(51):e17175. PubMed ID: 31860944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prevalence of acromegaly in a large US health plan database.
    Burton T; Le Nestour E; Neary M; Ludlam WH
    Pituitary; 2016 Jun; 19(3):262-7. PubMed ID: 26792654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival.
    Lau M; Le A; El-Serag HB
    Am J Gastroenterol; 2006 Nov; 101(11):2485-92. PubMed ID: 17029617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.